Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET
Company Participants
Bill Newby - Head, IR
Andrew Dudum - Co-Founder and CEO
Yemi Okupe - CFO
Patrick Carroll - Chief Medical Officer
Conference Call Participants
Allen Lutz - Bank of America
Maria Ripps - Canaccord
Daniel Grosslight - Citi
Eric Percher - Nephron Research
Ryan MacDonald - Needham
Aaron Kessler - Seaport Research
Jonna Kim - TD Cowen
Jailendra Singh - Truist Securities
Operator
Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to Hims & Hers Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Thank you.
I would now like to turn the conference over to Bill Newby, Head of Investor Relations. Bill, you may begin.
Bill Newby
Good afternoon, everyone, and welcome to the Hims & Hers Health third quarter 2024 earnings call. Today, after the market closed, we released this quarter's shareholder letter, a copy of which you can find on our website at investors.hims.com.
On the call with me today is Andrew Dudum, our Co-Founder and Chief Executive Officer; Yemi Okupe, our Chief Financial Officer; and Dr. Patrick Carroll, our Chief Medical Officer.
Before I hand it over to Andrew, I need to remind you of legal safe-harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on, among other things, our current market, competitors and regulatory expectations, and are subject to risks and uncertainties that could cause actual results to vary materially. We take no obligation to update publicly any forward-looking statement after this call, whether as a result of new information, future events, changes in assumptions, or otherwise.
Please see our most recently filed 10-K and 10-Q reports for a discussion of risk factors as they relate to forward-looking statements. In today's presentation, we will also have certain non-GAAP financial measures. We refer you to the reconciliation tables to the most directly comparable GAAP financial measures contained in today's press release and shareholder letter. You can find this information as well as a link to today's webcast at investors.hims.com. After the call, this webcast will be archived on the website for 12 months.
And with that, I will turn the call over to Andrew.
Andrew Dudum